✦ LIBER ✦

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

✍ Scribed by Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver; Charles N. Ellis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, multicenter, double-blind,

✍ Robert Bissonnette; Kim Papp; Yves Poulin; Gilles Lauzon; Launa Aspeslet; Robert 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Efficacy of ISA247 in plaque psoriasis:

✍ K Papp; R Bissonnette; L Rosoph; N Wasel; CW Lynde; G Searles; NH Shear; RB Huiz 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 206 KB

A phase IV randomized, double-blind, pla

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy, safety, and gastrointestinal t

✍ R. Buynak; D. Shapiro; A. Okamoto; C. Lange; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Clinical Efficacy of Efalizumab in Patie

✍ David M. Pariser; Kenneth B. Gordon; Kim A. Papp; Craig L. Leonardi; Paul Kwon; 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

A randomized double-blind placebo contro

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB